Annual report pursuant to Section 13 and 15(d)

Debt and Interest (Tables)

v3.6.0.2
Debt and Interest (Tables)
12 Months Ended
Dec. 31, 2016
Debt Disclosure [Abstract]  
Schedule Of Interest Expenses
Total debt consists of the following as of December 31, 2016 and December 31, 2015:
 
 
 
December 31,
 
 
 
 
 
($ in thousands)
 
2016
 
2015
 
Interest rate
 
Maturity
 
IDB Note
 
$
14,929
 
$
14,009
 
2.25%
 
Feb - 2018
 
NSC Note
 
 
3,608
 
 
10,000
 
8.00%
 
Sep - 2018
 
Opus Credit Facility
 
 
7,000
 
 
-
 
12.00%
 
Sep - 2018
 
Helocyte Convertible Note, at fair value
 
 
1,031
 
 
-
 
5.00% - 8.00%
 
Dec - 2017
 
Helocyte Convertible Note, at fair value
 
 
2,051
 
 
-
 
5.00% - 8.00%
 
March - 2018
 
Helocyte Convertible Note, at fair value
 
 
1,405
 
 
-
 
5.00% - 8.00%
 
May - 2018
 
Avenue Convertible Note, at fair value
 
 
200
 
 
-
 
5.00% - 8.00%
 
June - 2018
 
Total notes payable
 
 
30,224
 
 
24,009
 
 
 
 
 
Less: Discount on notes payable
 
 
2,009
 
 
835
 
 
 
 
 
Total notes payable, long-term
 
$
28,215
 
$
23,174
 
 
 
 
 
Schedule Of Interest Expenses For Debt Arrangements
The following table shows the details of interest expense for all debt arrangements during the periods presented. Interest expense includes contractual interest and amortization of the debt discount and amortization of fees represents fees associated with loan transaction costs, amortized over the life of the loan:
 
 
 
For the Years Ended December 31,
 
($ in thousands)
 
2016
 
2015
 
2014
 
IDB Note
 
 
 
 
 
 
 
 
 
 
Interest
 
$
328
 
$
314
 
$
292
 
Amortization of fees
 
 
1
 
 
5
 
 
4
 
Total IDB Note
 
 
329
 
 
319
 
 
296
 
 
 
 
 
 
 
 
 
 
 
 
NSC Debt
 
 
 
 
 
 
 
 
 
 
Interest
 
 
599
 
 
690
 
 
-
 
Amortization of fees
 
 
1,270
 
 
309
 
 
-
 
Total NSC Debt
 
 
1,869
 
 
999
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Opus Credit Facility
 
 
 
 
 
 
 
 
 
 
Interest
 
 
192
 
 
-
 
 
-
 
Amortization of fees
 
 
195
 
 
-
 
 
-
 
Total Opus Note
 
 
387
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Ovamed
 
 
 
 
 
 
 
 
 
 
Interest
 
 
-
 
 
166
 
 
154
 
Total Ovamed
 
 
-
 
 
166
 
 
154
 
 
 
 
 
 
 
 
 
 
 
 
LOC Fees
 
 
 
 
 
 
 
 
 
 
Interest
 
 
11
 
 
-
 
 
-
 
Total LOC
 
 
11
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Helocyte Convertible Note
 
 
 
 
 
 
 
 
 
 
Interest
 
 
61
 
 
-
 
 
-
 
Financing fee
 
 
962
 
 
-
 
 
-
 
Total Helocyte Convertible Note
 
 
1,023
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Avenue Convertible Note
 
 
 
 
 
 
 
 
 
 
Financing fee
 
 
70
 
 
-
 
 
-
 
Total Avenue Convertible Note
 
 
70
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Hercules Debt
 
 
 
 
 
 
 
 
 
 
Interest (1)
 
 
-
 
 
-
 
 
845
 
Amortization of fees
 
 
-
 
 
-
 
 
43
 
Total Hercules Debt
 
 
-
 
 
-
 
 
888
 
 
 
 
 
 
 
 
 
 
 
 
D&O Insurance
 
 
 
 
 
 
 
 
 
 
Interest
 
 
1
 
 
-
 
 
-
 
Total D&O Insurance
 
 
1
 
 
-
 
 
-
 
Total Interest Expense and Financing Fee
 
$
3,690
 
$
1,484
 
$
1,338
 
 
(1)
Interest expense related to the Company’s loan with Hercules was $0.8 million, including $0.4 million related to accretion of the debt discount for the year ended December 31, 2014.